94 related articles for article (PubMed ID: 11601098)
1. [Double blockade should protect the stomach. New approach to rheumatism].
MMW Fortschr Med; 2001 Sep; 143(38):58. PubMed ID: 11601098
[No Abstract] [Full Text] [Related]
2. Licofelone (Merckle).
Ding C; Cicuttini F
IDrugs; 2003 Aug; 6(8):802-8. PubMed ID: 12917777
[TBL] [Abstract][Full Text] [Related]
3. Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis.
Alvaro-Gracia JM
Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i21-5. PubMed ID: 14752172
[TBL] [Abstract][Full Text] [Related]
4. COX-LOX inhibition: current evidence for an emerging new therapy.
Skelly MM; Hawkey CJ
Int J Clin Pract; 2003 May; 57(4):301-4. PubMed ID: 12800462
[TBL] [Abstract][Full Text] [Related]
5. Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis.
Vidal C; Gómez-Hernández A; Sánchez-Galán E; González A; Ortega L; Gómez-Gerique JA; Tuñón J; Egido J
J Pharmacol Exp Ther; 2007 Jan; 320(1):108-16. PubMed ID: 17015640
[TBL] [Abstract][Full Text] [Related]
6. Safety of anti-inflammatory treatment--new ways of thinking.
Brune K
Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i16-20. PubMed ID: 14752171
[TBL] [Abstract][Full Text] [Related]
7. Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone.
Cicero AF; Derosa G; Gaddi A
Drugs Aging; 2005; 22(5):393-403. PubMed ID: 15903352
[TBL] [Abstract][Full Text] [Related]
8. The lipoxygenase-cyclooxygenase inhibitor licofelone prevents thromboxane A2-mediated cardiovascular derangement triggered by the inflammatory peptide fMLP in the rabbit.
Rotondo S; Dell'Elba G; Manarini S; Cerletti C; Evangelista V
Eur J Pharmacol; 2006 Sep; 546(1-3):95-101. PubMed ID: 16920097
[TBL] [Abstract][Full Text] [Related]
9. The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial.
Bias P; Buchner A; Klesser B; Laufer S
Am J Gastroenterol; 2004 Apr; 99(4):611-8. PubMed ID: 15089890
[TBL] [Abstract][Full Text] [Related]
10. [Homeopathy suppresses COX- and LOX activity. Soft therapy for arthrosis ills].
MMW Fortschr Med; 2004 Jan; 146(5):47. PubMed ID: 15035421
[No Abstract] [Full Text] [Related]
11. Standard NSAIDs vs. COX-2 inhibitors.
Johns Hopkins Med Lett Health After 50; 2002 Jan; 13(11):3. PubMed ID: 14727601
[No Abstract] [Full Text] [Related]
12. [Adverse effects of NSAID are insidious. No pain--despite life threatening gastric hemorrhage].
MMW Fortschr Med; 2002 Sep; 144(37):55. PubMed ID: 12380342
[No Abstract] [Full Text] [Related]
13. The COX 2 selective inhibitors: what the newspapers have not told you.
Simon LS
Bull NYU Hosp Jt Dis; 2007; 65(3):229-41. PubMed ID: 17922675
[No Abstract] [Full Text] [Related]
14. [Role of prostaglandins in the pathogenesis of stomach ulcer and gastropathy caused by non-steroid anti-inflammatory drugs].
Lazebnik LB; Tkachenko VN; Kolomiets EV
Eksp Klin Gastroenterol; 2005; (1):4-7, 106. PubMed ID: 15991845
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal tolerance of [2,2-dimethyl-6-(4-chlorophenyl-7-phenyl- 2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid in the rat.
Laufer S; Tries S; Augustin J; Elsässer R; Algate DR; Atterson PR; Munt PL
Arzneimittelforschung; 1994 Dec; 44(12):1329-33. PubMed ID: 7848352
[TBL] [Abstract][Full Text] [Related]
16. Activity and potential role of licofelone in the management of osteoarthritis.
Cicero AF; Laghi L
Clin Interv Aging; 2007; 2(1):73-9. PubMed ID: 18044077
[TBL] [Abstract][Full Text] [Related]
17. Means, responders, and meaning: evaluation of clinical trials in osteoarthritis.
Schnitzer TJ
Arthritis Rheum; 2003 Nov; 48(11):3001-3. PubMed ID: 14613258
[No Abstract] [Full Text] [Related]
18. [Mobility and quality of life for arthrosis and rheumatism patients. Modern pain management with selective cox-2 inhibition].
MMW Fortschr Med; 2002 Jul; 144(29-30):52. PubMed ID: 12219613
[No Abstract] [Full Text] [Related]
19. Evidence based medicine (EBM) in practice: applying relative risk and relative risk reduction.
Schoenfeld P
Am J Gastroenterol; 2004 Nov; 99(11):2084-5. PubMed ID: 15554983
[No Abstract] [Full Text] [Related]
20. [Migraine, juvenile rheumatoid arthritis, prevention of cancer. Potential of coxibs has not been exhausted].
MMW Fortschr Med; 2004 Apr; 146(17):57. PubMed ID: 15224911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
